Enorama Pharma AB (publ) (STO: ERMA) Stock Analysis & Fundamentals

ERMAEnorama Pharma AB (publ)

STO · SE · Healthcare · Drug Manufacturers - Specialty & Generic · enorama.se

0.6040SEK-13.47%Mkt Cap: 4.31M $P/E: —1d ago

Enorama Pharma AB (publ), a pharmaceutical company, develops, manufactures, and sells tobacco-free white snus in Sweden. It offers its products under the NIC-S brand name. The company was incorporated in 2006 and is base…

Industry Peers

Drug Manufacturers - Specialty & Generic

Screen all

MRK

MERCK Kommanditgesellschaft auf Aktien

$65.24BUSDP/E 23.7

HLN

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

United Therapeutics Corporation

Swedish Orphan Biovitrum AB

$15.39BUSDP/E 118.0

NBIX

Neurocrine Biosciences, Inc.

Elanco Animal Health Incorporat

Hims & Hers Health, Inc.

Lantheus Holdings Inc

$6.56BUSDP/E 24.0

AMRX

Amneal Pharmaceuticals, Inc.

$6.23BUSDP/E 37.3

INDV

Indivior PLC Ordinary Shares

$4.61BUSDP/E 14.0

HIK

Hikma Pharmaceuticals PLC

$4.32BUSDP/E 12.5

AMLX

Amylyx Pharmaceuticals Inc. Common Stock

Laboratorios Farmaceuticos Rovi, S.A.

$3.34BUSDP/E 16.6

SUPN

Supernus Pharmaceuticals, Inc.

$2.82BUSD

Key Statistics

Company

Market Cap4.31M $

Enterprise Value4.11M $

Revenue (TTM)311.35K $

Gross Profit-1.44M $

Net Income (TTM)-7.19M $

Revenue/Share0.0037 USD

Last Price0.6040 SEK

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees4

CountrySE

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA-0.81

EV/Revenue13.20

P/S23.49

P/B-3.26

EPS (TTM)-0.81

EPS (Forward)—

52W Range

0.211014% of range3.000

52W High3.000 SEK

52W Low0.2110 SEK

Profitability

Gross Margin-549.22%

Oper. Margin-8608.82%

EBITDA Margin0.00%

Profit Margin-2743.30%

ROE320.41%

ROA-909.45%

Growth

Revenue Growth-81.50%

Earnings Growth—

Cash Flow & Leverage

Operating CF-5.67M $

CapEx (TTM)—

FCF Margin-458.77%

FCF Yield-33.15%

Net Debt-200.68K $

Net Debt/EBITDA0.04

Balance Sheet

Debt/Equity0.00

Current Ratio0.21

Quick Ratio0.12

Book Value/Sh-0.3140 SEK

Cash/Share0.0280 SEK

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 SEK

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.74.59M

Float15.81M

Insiders91.12%

Institutions1.51%

Technical

SMA 500.3635 (+66.2%)

SMA 2000.9614 (-37.2%)

Beta—

S&P 52W Chg18.16%

Avg Vol (30d)159.80K

Avg Vol (10d)570.80K

Technical Indicators

RSI (14)55.9

MACD0.1044

MACD Signal0.0604

MACD Hist.+0.0439

BB Upper0.9048 SEK

BB Middle0.4268 SEK

BB Lower-0.0513 SEK

BB Width224.02%

ATR (14)0.2188 SEK

Vol Ratio (20d)1.56x